The global Liver Cancer Therapeutics Market Size, valued at USD 3.12 billion in 2023, is projected to grow significantly and reach USD 15.69 billion by 2032, expanding at an impressive CAGR of 19.21% during the forecast period from 2024 to 2032. This substantial growth reflects a rising global burden of liver cancer, increasing investments in oncology research, and the emergence of targeted and...